These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 22475918)

  • 21. Is methylene diphosphonate bone scan necessary for initial staging of Ewing sarcoma if 18F-FDG PET/CT is performed?
    Ulaner GA; Magnan H; Healey JH; Weber WA; Meyers PA
    AJR Am J Roentgenol; 2014 Apr; 202(4):859-67. PubMed ID: 24660717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential diagnosis between secondary and tertiary hyperparathyroidism in a case of a giant-cell and brown tumor containing mass. Findings by (99m)Tc-MDP, (18)F-FDG PET/CT and (99m)Tc-MIBI scans.
    Gedik GK; Ata O; Karabagli P; Sari O
    Hell J Nucl Med; 2014; 17(3):214-7. PubMed ID: 25397627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting bone metastasis in head and neck tumors.
    Al-Bulushi NK; Abouzied ME
    Nucl Med Commun; 2016 Jun; 37(6):583-8. PubMed ID: 26813992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (18)F-FDG PET/CT and (99m)Tc-MDP imaging of non-small cell lung carcinoma osseous metastases.
    Komissarova M; Wong KK; Fig LM
    J Nucl Med Technol; 2012 Mar; 40(1):66-7, 70. PubMed ID: 22279236
    [No Abstract]   [Full Text] [Related]  

  • 25. Detection of bone metastases in breast cancer patients in the PET/CT era: Do we still need the bone scan?
    Caglar M; Kupik O; Karabulut E; Høilund-Carlsen PF
    Rev Esp Med Nucl Imagen Mol; 2016; 35(1):3-11. PubMed ID: 26514321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by
    Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W
    Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymmetric (99m)Tc-MDP uptake in mineralized tendons might mimic bone lesions: heterotopic tendon mineralization on a (99m)Tc-MDP bone scan and a (18)F-FDG PET/CT scan.
    Chen YR; Hsieh TC; Yen KY; Shen YY; Kao CH
    Clin Nucl Med; 2014 May; 39(5):480-2. PubMed ID: 23877525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discordant findings of skeletal metastasis between tc 99M MDP bone scans and F18 FDG PET/CT imaging for advanced breast and lung cancers--two case reports and literature review.
    Chen YW; Huang MY; Hsieh JS; Hou MF; Chou SH; Lin CL
    Kaohsiung J Med Sci; 2007 Dec; 23(12):639-46. PubMed ID: 18192101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy.
    Franzius C; Sciuk J; Daldrup-Link HE; Jürgens H; Schober O
    Eur J Nucl Med; 2000 Sep; 27(9):1305-11. PubMed ID: 11007511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas.
    Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
    Anticancer Res; 2005; 25(6C):4439-44. PubMed ID: 16334123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of 18F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and prostate carcinoma: a comparison with FDG PET/CT and 99mTc-MDP bone scan.
    Damle NA; Bal C; Bandopadhyaya GP; Kumar L; Kumar P; Malhotra A; Lata S
    Jpn J Radiol; 2013 Apr; 31(4):262-9. PubMed ID: 23377765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone metastasis versus bone marrow metastasis? Integration of diagnosis by (18)F-fluorodeoxyglucose positron emission/computed tomography in advanced malignancy with super bone scan: two case reports and literature review.
    Lin CY; Chen YW; Chang CC; Yang WC; Huang CJ; Hou MF
    Kaohsiung J Med Sci; 2013 Apr; 29(4):229-33. PubMed ID: 23541269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of the Prostate Cancer Bone Metastases: Is It Feasible to Compare 18F-fluorocholine PET/CT, 18F-fluorodeoxyglucose PET/CT and 99mTc-methyl Diphosphonate Bone Scintigraphy?
    Pietrzak AK; Czepczynski R; Wierzchoslawska E; Cholewinski W
    Urol J; 2018 Sep; 15(5):242-247. PubMed ID: 29681049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing whole body (18)F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer.
    Yang SN; Liang JA; Lin FJ; Kao CH; Lin CC; Lee CC
    J Cancer Res Clin Oncol; 2002 Jun; 128(6):325-8. PubMed ID: 12073051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accidental finding of bladder cancer in 99mTc methylene diphosphonate whole-body bone scan.
    Lin Y; Lu YY; Wang HY; Tsai SC; Lin WY
    Clin Nucl Med; 2013 Aug; 38(8):643-5. PubMed ID: 23510879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of hormone receptor status in comparison of 18F -FDG-PET/CT and 99mTc-MDP bone scintigraphy for evaluating bone metastases in patients with breast cancer: single center experience.
    Teke F; Teke M; Inal A; Kaplan MA; Kucukoner M; Aksu R; Urakci Z; Tasdemir B; Isikdogan A
    Asian Pac J Cancer Prev; 2015; 16(1):387-91. PubMed ID: 25640386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer.
    Hahn S; Heusner T; Kümmel S; Köninger A; Nagarajah J; Müller S; Boy C; Forsting M; Bockisch A; Antoch G; Stahl A
    Acta Radiol; 2011 Nov; 52(9):1009-14. PubMed ID: 21969709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral bone involvement of intravascular large B-cell lymphoma on 99mTc-MDP bone scan and 18F-FDG PET/CT.
    Oh SY; Cheon GJ; Jeong E; Lee S; Park TG; Pahk K; Choe JG
    Clin Nucl Med; 2012 Aug; 37(8):810-1. PubMed ID: 22785520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Focused regional FDG PET/CT detects more osseous metastases than does whole-body PET/CT.
    Mojtahedi A; Solomon SB; Ulaner GA
    Clin Nucl Med; 2013 Mar; 38(3):217-8. PubMed ID: 23357824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT.
    Krüger S; Buck AK; Mottaghy FM; Hasenkamp E; Pauls S; Schumann C; Wibmer T; Merk T; Hombach V; Reske SN
    Eur J Nucl Med Mol Imaging; 2009 Nov; 36(11):1807-12. PubMed ID: 19504092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.